CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Non-Current Deffered Revenue (2022 - 2024)

CDT Equity's (CDT) quarterly Non-Current Deffered Revenue came in at $5.7 million in Q2 2024, little changed on a QoQ basis from $5.7 million in Q4 2023.

CDT Equity (CDT) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends

CDT Equity (CDT) has 3 years of Non-Current Deffered Revenue data on file, last reported at $5.7 million in Q2 2024.

  • Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $5.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $5.7 million (changed N/A YoY) and the FY2023 annual result came in at $5.7 million, up 40.53% from the prior year.
  • Non-Current Deffered Revenue held at $5.7 million in Q2 2024, from $5.7 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $5.7 million in Q4 2023 to a low of $2.7 million in Q3 2023.
  • A 3-year average of $4.4 million and a median of $4.1 million in 2022 frame the typical range for Non-Current Deffered Revenue.
  • The widest YoY moves for Non-Current Deffered Revenue: up 40.53% in 2023, down 29.03% in 2023.
  • Tracing CDT's Non-Current Deffered Revenue over 3 years: stood at $4.1 million in 2022, then surged by 40.53% to $5.7 million in 2023, then changed by 0.0% to $5.7 million in 2024.
  • The last three Non-Current Deffered Revenue figures came in at $5.7 million (Q2 2024), $5.7 million (Q4 2023), and $2.7 million (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 147.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CDT Equity 1.55 Mn 1.55 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 5.74 Mn
Dec 31, 2023 5.74 Mn
Sep 30, 2023 2.67 Mn
Dec 31, 2022 4.08 Mn
Sep 30, 2022 3.76 Mn